Latest Health News

Bioxyne Limited has posted a record $17.2 million in quarterly revenue for Q2 FY26, driven by strong growth in its cannabis and psychedelics segments alongside strategic international expansions.

Tetratherix Limited (ASX, TTX) reports significant progress in clinical trials, strategic partnerships, and manufacturing capacity, positioning itself for near-term commercialisation and sustained innovation.

Clever Culture Systems has expanded its APAS Independence installed base to 27 instruments globally and surpassed $1 million in annual recurring revenue, underpinned by strong sales momentum and customer validation.

Strategic Elements Ltd reports steady progress in its cutting-edge ventures across automation, AI, and material science, supported by a strong cash position and government-backed innovation incentives.

Firebrick Pharma has commenced commercial manufacturing and export of its new Nasodine Throat Spray, marking a significant step in its international expansion. The company also reported a 15% increase in cash sales and reduced operating costs, signalling improving financial health.

RLF AgTech Ltd has reported a record December quarter with $10.4 million in cash receipts, driven by strong performances across its LiquaForce, China, and newly operational Australian divisions. Positive field trial results in Vietnam and ongoing expansion in Southeast Asia underpin the company’s growth outlook.

West African Resources Limited reported a robust cash flow for the December 2025 quarter, ending with a strong cash position of A$584.1 million. The company’s operating activities generated significant cash inflows, offsetting substantial investing and financing outflows.

West African Resources has met its 2025 gold production and cost targets for the fifth consecutive year, reporting robust quarterly results and promising exploration outcomes that suggest extended mine life at Sanbrado.

Thrive Tribe Technologies has raised approximately $200,000 through a discounted share placement, aiming to bolster working capital and support its health and wellness platform growth.

3D Energi Limited has voluntarily suspended trading of its shares on the ASX as it navigates funding challenges and the future of its VIC/P79 exploration permit. The suspension will last until early February or until further updates are provided.

HeraMED Limited has completed a $3.2 million placement to fund its global rollout of digital maternity care solutions, backed by new and existing institutional investors.

Adheris Health has received the final $6.1 million holdback payment from its Australian and New Zealand business sale, bringing total proceeds to $33.1 million and setting the stage for future earn-out payments.